Mar 31
Fiscal year end
Show active companies only
616 companies
1859 Capital Services Ltd
United Kingdom
1859 Cloud Ltd
United Kingdom
1859 Origin Fund LP
Cayman Islands
36one Us Feeder LP
Delaware
EGHT
8x8, Inc.
8x8, Inc.
California
NYSE
A&Q Masters Fund
Connecticut
A&Q Multi-Strategy Fund
Connecticut
A.D.Works. Co., Ltd.
Japan
ABMD
ABIOMED, Inc.
ABIOMED, Inc.
Massachusetts
NASDAQ
ACGT DNA Technologies Corp
Ontario, Canada
AIS Holdings Group, Inc.
We are a start-up stage company with a fiscal year end of March 31. Effective February 28, 2018, our wholly owned subsidiary, which we operate exclusively through at this time, AIS Japan, purchased a "Software Platform Package," from Herol Gaibin in the amount of 2,000,000 JPY ($18,822).
Japan
AMG Funds I
Connecticut
XPEPX
AMG Pantheon Fund, LLC
Connecticut
ACST
Acasti Pharma Inc
Acasti Pharma is a biopharmaceutical innovator advancing a potentially best-in-class cardiovascular drug, CaPre® (omega-3 phospholipid), for the treatment of hypertriglyceridemia, a chronic condition affecting an estimated one third of the U.S. population.
Quebec, Canada
NASDAQ
Achison Inc
New York
ATXG
Addentax Group Corp
Addentax Group Corp.
China
NASDAQ
ADMT
Adm Tronics Unlimited Inc
ADM Tronics Unlimited, Inc.
New Jersey
OTC
WMS
Advanced Drainage Systems, Inc.
Advanced Drainage Systems, Inc.
Ohio
NYSE
ASNB
Advansource Biomaterials Corp
AdvanSource Biomaterials Corp.
Massachusetts
OTC
AERO
AeroGrow International, Inc.
Headquartered in Boulder, Colorado, AeroGrow International Inc.
Colorado
OTC